Metformin in CKD — PSA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Review metformin dose and renal function
At eGFR 30 to 44, metformin requires dose review and closer renal monitoring; it is not automatically continued unchanged. It should not be used below eGFR 30. The broader glucose-lowering plan should reflect glycaemia, comorbidity and hypoglycaemia risk.
Reference: NICE NG28: Type 2 diabetes in adults: https://www.nice.org.uk/guidance/ng28/chapter/recommendations